Compare Eli Lilly And Co (LLY) vs Monster Beverage Corp (MNST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Monster Beverage Corp — how do they compare? Eli Lilly And Co trades at $1,179.27 (market cap $1.04T), while Monster Beverage Corp trades at $43.64 (market cap $85.51B). The key difference: Eli Lilly And Co is far larger — about 12.2× Monster Beverage Corp's market cap, and Eli Lilly And Co pays a 0.59% dividend while Monster Beverage Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Eli Lilly And Co for 93 Days and Monster Beverage Corp for 72 Days on average.
| LLY | MNST | |
|---|---|---|
Market Cap | $1.04T | $85.51B |
Volume | 3,064,878 | 8,569,709 |
Sector | Health | Consumer Staples |
52-Week High | $1.28K | $49.97 |
52-Week Low | $799.57 | $33.16 |
Typical Hold Time | 93 Days | 72 Days |
Enterprise Value | $1.09T | $83.81B |
Dividend Yield | 0.59% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,169.93, down 1.58% on the day, but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The company's weight-loss drug portfolio continues to drive exceptional performance, with Q2 2026 EPS of $8.38 beating expectations by 31%. Technical indicators show bullish moving averages while fundamentals reveal impressive 83.4% gross margins and 102.44% ROE. Recent clinical trial successes for next-generation obesity treatments position Lilly for continued market leadership.
LLY presents a compelling growth story with dominant positioning in the expanding obesity/diabetes market, though elevated valuations (P/E 39.26) and regulatory risks require monitoring. Analyst consensus remains strongly bullish with $1,350 price target representing 15% upside. The primary investment thesis centers on pipeline execution and market expansion opportunities, balanced against competitive pressures and valuation concerns.
Monster Beverage (MNST) trades at $43.65, up 1.8% with bullish technical signals and strong fundamentals. The stock shows consistent earnings beats with Q2 2026 EPS of $0.30 exceeding expectations. Revenue grew to $8.29B in 2025 with impressive 23.08% net margins and zero long-term debt. Recent 1:2 stock split on August 11, 2026, enhances accessibility while international sales surge 35% in Q2 2026.
MNST presents growth potential through international expansion and clean balance sheet, but faces valuation concerns with P/E of 40.42. Analyst consensus targets $98.22 (52% buy ratings) suggesting significant upside. Key risks include regulatory challenges in markets like India and competitive pressure from beverage giants. The stock's premium valuation requires sustained high growth to justify current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Monster Beverage Corp
Monster Beverage is a leader in the energy drink subsegment of the beverage industry. The Monster trademark anchors the portfolio, and notable offerings include Monster Energy and Monster Ultra. The firm has also started to incubate new trademarks for emerging enclaves of the energy space, like Reign in performance energy. It is primarily a brand owner, outsourcing most of its manufacturing processes to third-party copackers. It primarily uses the Coca-Cola bottling system for distribution after a strategic agreement in which Coke became Monster's largest shareholder (nearly 20%) and that also included the exchange of certain businesses between the two firms. Most of Monster's revenue is generated in the United States, though international geographies are increasing in the mix.
Read more on MNST →
